tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

SNPS · Q1 2026 Earnings

Synopsys

Reported February 25, 2026

30-second summary

Synopsys beat the high end of its Q1 FY2026 non-GAAP EPS guide by $0.19 ($3.77 vs $3.58 high) on revenue of $2.409B that landed at the top of the $2.365–2.415B range, and nudged the FY2026 non-GAAP EPS midpoint up $0.06 to $14.42 while reaffirming revenue at $9.61B. Q1 non-GAAP operating margin printed at 42.1% — ~160bps above the reaffirmed FY 40.5% midpoint — while GAAP operating margin was 8.4% on heavy Ansys acquisition-related amortization. Design IP fell again to $407M (-6.5% YoY, flat sequentially with Q4 FY2025's $407M) — exactly the "muted" trajectory management warned about, with no royalty-deal disclosure yet. The Q1 print validates the conservatively reset bar but does nothing to resolve the IP question; the FY EPS raise is small enough to read as quarterly conservatism rather than a structural upgrade.

Headline numbers

EPS

Q1 FY2026

$3.77

Revenue

Q1 FY2026

$2.41B

+65.5% YoY

Gross margin

Q1 FY2026

73.5%

Free cash flow

Q1 FY2026

$0.82B

Operating margin

Q1 FY2026

8.4%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$2.41B+65.5%$2.25B+6.8%
EPS$3.77$2.90+30.0%
Gross margin73.5%71.0%+250bps
Operating margin8.4%5.4%+300bps
Free cash flow$0.82B

Guidance

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
RevenueQ1 FY2026$2,365-$2,415 million$2,409 million+0-44 million above guide (in-line with high end)Beat
Non-GAAP EPSQ1 FY2026$3.52-$3.58$3.77+0.19-0.25 above guideBeat
GAAP EPSQ1 FY2026$0.22-$0.41$0.34+0.00-0.12 above guide (in-line)Beat

New guidance

MetricPeriodGuideYoY
RevenueQ2 FY2026$2,225-$2,275 million+39-42% YoY
Non-GAAP EPSQ2 FY2026$3.11-$3.17
GAAP EPSQ2 FY2026$0.23-$0.43
Non-GAAP ExpensesQ2 FY2026

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Non-GAAP EPS
FY2026
$14.32-$14.40$14.38-$14.46+0.06-0.14 midpoint raise to $14.42 from $14.36Raised

Reaffirmed unchanged this quarter: Revenue ($9,560-$9,660 million), Non-GAAP Operating Margin (40.5% at midpoint), Operating Cash Flow (~$2,200 million), Free Cash Flow (~$1,900 million), Ansys Revenue Contribution ($2.9 billion at midpoint, growing double digits)

Segment performance

Q1 FY2026
SegmentQ1 FY2026YoY
Design Automation$2.002B+96.1%
Design IP$0.407B-6.5%
Time-based products revenue$951.5M
Upfront products revenue$741.5M
Maintenance and service revenue$715.7M

Platform metrics

Q1 FY2026
SegmentQ1 FY2026
Deferred revenue$2,880.0M

Profitability

Q1 FY2026
SegmentQ1 FY2026
Design Automation adjusted operating margin47.3%
Design IP adjusted operating margin16.2%
Operating cash flow (Q1)$856.8M

Other KPIs

Q1 FY2026
SegmentQ1 FY2026
Stock repurchase authorization$2.0B

Management tone

Q2 FY2025 agentic AI re-architecting → Q3 FY2025 IP breakage and headcount cuts → Q4 FY2025 transitional year with margin expansion as proof → Q1 FY2026 AI as amplifier and Ansys monetization timeline pushed to FY27.

Last quarter management framed the agentic AI narrative as something where current monetization was admittedly "broken" on the EDA software side. This quarter the framing flipped to outright confidence: "AI isn't disrupting our business, it's amplifying our strategic advantage." The pivot is sharp — three quarters ago management was on the back foot defending against AI disruption narratives in EDA; this quarter management is positioning Synopsys as the deterministic, accuracy-required vendor that probabilistic LLM-based competitors cannot replace. The "our agents cannot hallucinate" line is a competitive moat assertion, not a defensive one.

The Ansys monetization timeline shifted in a direction worth flagging. Last quarter joint Synopsys-Ansys solutions were framed as the H1 FY2026 unlock for EDA software monetization inflection. This quarter management said the technology delivery happens in 2026 but monetization of joint solutions starts in FY27. That is a quiet 12-month push-out of the revenue payoff narrative, even as the strategic framing strengthens. The exact quote: "2026 is the year we begin delivering on the technology promise of Synopsys plus Ansys" — note the careful word choice. Technology, not revenue.

The IP business commentary held the line from last quarter — "transitional year," "muted FY26 growth," "sequential improvement given roadmap and sales pipeline." But the addition this quarter was an active monetization disclosure: "We're in active conversations with a number of these partners, and I do expect that we will close a number of these conversations...move into an actual business in FY26." This is the first time management has framed value-based and token-based monetization conversations with hyperscaler IP customers as near-term closings rather than directional possibilities. The royalty-model commitment from Q4 FY2025 now has a specific customer class (hyperscalers) attached.

China commentary continued the hardening arc from last quarter — "China revenue declined slightly year over year, consistent with our outlook...the cumulative impact of the restrictions, both in entity list and technology, are truly having an impact." That is incrementally more attributive than last quarter (when it was just "challenged"), but the underlying assumption — no recovery — is unchanged.

The overall confidence level reads as a step up from Q4 FY2025's cautious posture, but the durable structural concerns (IP, China, Ansys timing) are intact. The bullish framing is on the technology and competitive narrative; the guidance behavior is still defensive.

Recurring themes management leaned on this quarter:

AI-driven design automation and agent engineers advancing rapidlyDigital twins and silicon-to-system engineering as competitive imperativeANSYS integration delivering joint solutions and cross-selling momentumMulti-die and advanced node leadership with 100% usage at 2nmIP portfolio sharpening focus toward interconnect and foundation IPPhysical AI and electrification driving long-term demand expansion

Risks management surfaced:

China headwinds persist from entity list and technology restrictionsIP business schedule delays on specific titles requiring prioritization of resourcesDesign starts in consumer, automotive, and industrial remain subdued despite recovery signalsGeopolitical and macro uncertainty continuing to impact operationsANSYS business revenue variability from 606 accounting and deal timing concentration

Answers to last quarter's watch list

Q1 FY2026 revenue execution against the $2.365–2.415B guide — Revenue printed $2.409B, at the top of the range, with non-GAAP EPS $0.19 above the high end. The "conservatively reset" framing held cleanly. The H1/H2 implied split is intact: Q1 actual $2.409B + Q2 guide midpoint $2.25B = $4.66B H1, leaving ~$4.95B for H2 against the reaffirmed $9.61B FY midpoint. Status: Resolved positively
Design IP sequential dollar trajectory — IP printed $407M in Q1 FY2026, exactly flat with Q4 FY2025's $407M. No sequential improvement, no further decline. The "muted" framing held literally — management's prediction was vindicated, but the underlying problem (zero sequential dollar growth two quarters running, -6.5% YoY) is not resolved. The hyperscaler royalty conversations and the FY26 closings management referenced are the load-bearing element for any H2 inflection. Status: Continue monitoring
First royalty-model IP contract disclosure — Management said active conversations are underway with hyperscaler IP partners and expects to close some in FY2026, but no specific named contract was disclosed this quarter. The framing tightened from Q4's "feel very good that an FY26 will be able to lock up some customers" to this quarter's "active conversations" and "move into an actual business in FY26." Direction is positive; concrete evidence is still pending. Status: Continue monitoring
First joint Synopsys-Ansys solutions delivery in H1 2026 — Management reframed this in a way that matters: technology delivery happens in 2026, but joint-solutions monetization is now expected to start in FY27. That is a pushout from the prior framing of H1 FY2026 monetization inflection. No specific product announcement or customer reference disclosed this quarter. Status: Resolved negatively on the monetization timing — the unlock is now ~12 months further out than implied last quarter.
China revenue magnitude and BIS posture — China declined slightly YoY as expected; no guide revision triggered. Management explicitly attributed the impact to entity list and technology restrictions, consistent with the "no improvement assumed" posture from Q4 FY2025. Status: Continue monitoring — the outcome matched the guide, but the underlying structural problem is unchanged.
Non-GAAP operating margin progression toward the 40.5% FY2026 midpoint — Q1 FY2026 non-GAAP operating margin printed at 42.1% (CFO Glaser, prepared remarks), ~160bps above the reaffirmed FY 40.5% midpoint — the Q1 print is actually ahead of the FY target, not behind it. GAAP operating margin was 8.4%, compressed by heavy Ansys acquisition-related amortization. DA segment adjusted operating margin came in at 47.3% (up from 41.5% in Q4 FY2025) and IP adjusted at 16.2% (up from 13.8%). The reaffirmation of the 40.5% FY midpoint despite a 42.1% Q1 print is itself a signal of embedded back-half conservatism. Status: Resolved positively on Q1; continue monitoring full-year trajectory.

What to watch into next quarter

Q2 FY2026 revenue execution against the $2.225–2.275B guide (+39–42% YoY off $1.60B baseline) — second consecutive quarter against the conservatively reset bar. Another beat-and-raise pattern at the high end would solidify the "Q4 FY2025 reset was sandbagging" thesis; an in-line-only print would reinforce that the FY guide has limited cushion.

Design IP sequential dollar inflection — IP has now printed $407M twice in a row. Q2 FY2026 needs to break above $407M to support the "sequential improvement" narrative management committed to. Another flat or down quarter would mean half the fiscal year has passed without the promised inflection, with only two quarters left to deliver the H2 IP recovery embedded in the FY guide.

First named royalty or value-based IP customer announcement — management said active conversations with hyperscaler partners are expected to close in FY26. A specific named contract in Q2 would be the first concrete evidence; absence by Q3 starts to look like delay.

FY2026 non-GAAP EPS guide trajectory — after raising FY EPS by only $0.06 against a $0.19 Q1 beat above the high end (and with the raise attributed to below-the-line items), management is implicitly building cushion into the back half. Watch whether Q2 produces another EPS beat and whether the FY guide is raised by more than the beat magnitude (signals durable upgrade) or less (signals continued conservatism on IP/China/Ansys timing).

Joint Synopsys-Ansys solutions technology delivery and customer references — monetization was pushed to FY27, but management still committed to delivering the "first wave of joint solutions" in 2026. Watch for product launches, customer references, or design-win disclosures in Q2 that would validate the technology promise.

Backlog trajectory — backlog ticked down $0.1B to $11.3B in Q1. Another sequential decline in Q2 would warrant attention given backlog is management's primary resilience anchor.

Sources

  1. Synopsys Q1 FY2026 press release (Exhibit 99.1), filed with the SEC: https://www.sec.gov/Archives/edgar/data/883241/000119312526071601/d921168dex991.htm
  2. Synopsys Q4 FY2025 Tapebrief (internal prior-quarter reference for guidance baselines and watch list).
  3. Synopsys Q3 FY2025 Tapebrief (internal prior-quarter reference for multi-quarter tone arc).
  4. Synopsys Q2 FY2025 Tapebrief (internal prior-quarter reference for multi-quarter tone arc).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.